Altoida, Inc. news
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences:<
The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and
The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and
Mission Based Media, a leader in podcasts about health, care and well-being, has launched a new podcast miniseries about Alzheimer`s disease. The Alzheimer`s Podcast miniseries provides insights and information for those who are diagnosed with Alzheimer`s disease and the people who care about them. The miniseries was created with support from Altoida, a leading platform to improve drug development, research, and care for patie
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. Antonella Santuccione Chadha as Chief Medi
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for i
Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics, announced today a partnership with Click Therapeutics, a leader in Digital Therapeutics™ as prescription medi
Altoida, Inc. an AI company pioneering next-generation neurological disease diagnostics, and GN Group, a global leader in intelligent audio solutions, have signed a multi-year strategic partnership to research and develop new digital biomarkers for identifying Mild Cognitive Impairment (MCI). The research will serve as the backbone for new augmented reality tools to help at-risk individuals gain timely and accurate health insights using GN Group’s device technologies and, ultimate